Literature DB >> 24666620

Usefulness of a low CHADS2 or CHA2DS2-VASc score to predict normal diagnostic testing in emergency department patients with an acute exacerbation of previously diagnosed atrial fibrillation.

Tyler W Barrett1, Robert L Abraham2, Wesley H Self3.   

Abstract

International guidelines do not specify what testing should be performed during emergency department (ED) evaluations for patients presenting with an exacerbation of previously diagnosed atrial fibrillation (AF). We hypothesized that low CHADS2 and CHA2DS2-VASc scores predict normal routine diagnostic testing in these patients. We conducted an analysis within a prospective observational cohort study at a university-affiliated hospital. We included patients with previously diagnosed AF and who presented to the ED primarily for an AF-related complaint. Logistic regression was used to analyze the association between CHADS2 and CHA2DS2-VASc scores and abnormal results for blood counts, electrolytes, cardiac markers, thyroid function, and chest x-rays. We included 216 patients in this analysis. The odds ratios (95% confidence interval) for each point increase in CHADS2 for abnormal blood counts, electrolytes, troponin I, brain natriuretic peptide, thyroid function, and chest x-ray were 1.28 (0.99 to 1.65), 1.48 (1.19 to 1.84), 1.42 (1.10 to 1.82), 1.66 (1.15 to 2.41), 0.95 (0.70 to 1.29), and 1.17 (0.94 to 1.44), respectively. The corresponding odds ratios (95% confidence interval) for each point increase in CHA2DS2-VASc were 1.17 (0.96 to 1.42), 1.27 (1.09 to 1.49), 1.30 (1.07 to 1.57), 1.57 (1.18 to 2.10), 0.98 (0.79 to 1.22), and 1.14 (0.97 to 1.33), respectively. Among ED patients with established AF who underwent evaluation for acutely symptomatic AF, nearly 3/4 of routine diagnostic tests return to normal. In conclusion, patients with CHADS2 or CHA2DS2-VASc score of 0 have the lowest likelihood of abnormal studies and may represent an easily identifiable group of patients who need fewer ED tests.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24666620      PMCID: PMC4160886          DOI: 10.1016/j.amjcard.2014.02.023

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  25 in total

1.  Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

Authors:  A John Camm; Paulus Kirchhof; Gregory Y H Lip; Ulrich Schotten; Irene Savelieva; Sabine Ernst; Isabelle C Van Gelder; Nawwar Al-Attar; Gerhard Hindricks; Bernard Prendergast; Hein Heidbuchel; Ottavio Alfieri; Annalisa Angelini; Dan Atar; Paolo Colonna; Raffaele De Caterina; Johan De Sutter; Andreas Goette; Bulent Gorenek; Magnus Heldal; Stefan H Hohloser; Philippe Kolh; Jean-Yves Le Heuzey; Piotr Ponikowski; Frans H Rutten
Journal:  Europace       Date:  2010-10       Impact factor: 5.214

2.  2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

Authors:  Valentin Fuster; Lars E Rydén; Davis S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; G Neal Kay; Jean-Yves Le Huezey; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; L Samuel Wann; Sidney C Smith; Silvia G Priori; N A Mark Estes; Michael D Ezekowitz; Warren M Jackman; Craig T January; James E Lowe; Richard L Page; David J Slotwiner; William G Stevenson; Cynthia M Tracy; Alice K Jacobs; Jeffrey L Anderson; Nancy Albert; Christopher E Buller; Mark A Creager; Steven M Ettinger; Robert A Guyton; Jonathan L Halperin; Judith S Hochman; Frederick G Kushner; Erik Magnus Ohman; William G Stevenson; Lynn G Tarkington; Clyde W Yancy
Journal:  Circulation       Date:  2011-03-07       Impact factor: 29.690

3.  An international view of how recent-onset atrial fibrillation is treated in the emergency department.

Authors:  Carly Rogenstein; Anne-Maree Kelly; Suzanne Mason; Sandra Schneider; Eddy Lang; Catherine M Clement; Ian G Stiell
Journal:  Acad Emerg Med       Date:  2012-11       Impact factor: 3.451

4.  2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association.

Authors:  A John Camm; Gregory Y H Lip; Raffaele De Caterina; Irene Savelieva; Dan Atar; Stefan H Hohnloser; Gerhard Hindricks; Paulus Kirchhof
Journal:  Europace       Date:  2012-08-24       Impact factor: 5.214

5.  An evaluation of the CHADS₂ stroke risk score in patients with atrial fibrillation who undergo percutaneous coronary revascularization.

Authors:  Juan M Ruiz-Nodar; Francisco Marín; Sergio Manzano-Fernández; José Valencia-Martín; José A Hurtado; Vanessa Roldán; Javier Pineda; Eduardo Pinar; Francisco Sogorb; Mariano Valdés; Gregory Y H Lip
Journal:  Chest       Date:  2010-09-23       Impact factor: 9.410

6.  Atrial fibrillation and flutter outcomes and risk determination (AFFORD): design and rationale.

Authors:  Tyler W Barrett; Alan B Storrow; Cathy A Jenkins; Frank E Harrell; Karen F Miller; Kelly M Moser; Stephan Russ; Dan M Roden; Dawood Darbar
Journal:  J Cardiol       Date:  2011-08-04       Impact factor: 3.159

Review 7.  Atrial fibrillation: current knowledge and future directions in epidemiology and genomics.

Authors:  Jared W Magnani; Michiel Rienstra; Honghuang Lin; Moritz F Sinner; Steven A Lubitz; David D McManus; Josée Dupuis; Patrick T Ellinor; Emelia J Benjamin
Journal:  Circulation       Date:  2011-11-01       Impact factor: 29.690

8.  Estimation of total incremental health care costs in patients with atrial fibrillation in the United States.

Authors:  Michael H Kim; Stephen S Johnston; Bong-Chul Chu; Mehul R Dalal; Kathy L Schulman
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-05-03

9.  Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation.

Authors:  Keiko Nakagawa; Tadakazu Hirai; Shutaro Takashima; Nobuyuki Fukuda; Kazumasa Ohara; Etsuko Sasahara; Yoshiharu Taguchi; Nobuhiro Dougu; Takashi Nozawa; Kortaro Tanaka; Hiroshi Inoue
Journal:  Am J Cardiol       Date:  2011-01-19       Impact factor: 2.778

10.  Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.

Authors:  Gregory Y H Lip; Robby Nieuwlaat; Ron Pisters; Deirdre A Lane; Harry J G M Crijns
Journal:  Chest       Date:  2009-09-17       Impact factor: 9.410

View more
  1 in total

Review 1.  Managing atrial fibrillation.

Authors:  Clare L Atzema; Tyler W Barrett
Journal:  Ann Emerg Med       Date:  2015-02-18       Impact factor: 5.721

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.